BACKGROUND: Some of the genetic vulnerability for addiction may be mediated by impulsivity. This study investigated relationships among impulsivity, substance use problems and six neurexin-3 (NRXN3) polymorphisms. Neurexins (NRXNs) are presynaptic transmembrane proteins that play a role in the development and function of synapses. METHODS: Impulsivity was assessed with the Barratt Impulsiveness Scale Version 11 (BIS-11), the Boredom Proneness Scale (BPS) and the TIME paradigm; alcohol problems with the Michigan Alcoholism Screening Test (MAST); drug problems with the Drug Abuse Screening Test (DAST-20); and regular tobacco use with a single question. Participants (n=439 Caucasians, 64.7% female) donated buccal cells for genotyping. Six NRXN3 polymorphisms were genotyped: rs983795, rs11624704, rs917906, rs1004212, rs10146997 and rs8019381. A dual luciferase assay was conducted to determine whether allelic variation at rs917906 regulated gene expression. RESULTS: In general, impulsivity was significantly higher in those who regularly used tobacco and/or had alcohol or drug problems. In men, there were modest associations between rs11624704 and attentional impulsivity (p=0.005) and between rs1004212 and alcohol problems (p=0.009). In women, there were weak associations between rs10146997 and TIME estimation (p=0.03); and between rs1004212 and drug problems (p=0.03). The dual luciferase assay indicated that C and T alleles of rs917906 did not differentially regulate gene expression in vitro. CONCLUSIONS: Associations between impulsivity, substance use problems and polymorphisms in NRXN3 may be gender specific. Impulsivity is associated with substance use problems and may provide a useful intermediate phenotype for addiction.
BACKGROUND: Some of the genetic vulnerability for addiction may be mediated by impulsivity. This study investigated relationships among impulsivity, substance use problems and six neurexin-3 (NRXN3) polymorphisms. Neurexins (NRXNs) are presynaptic transmembrane proteins that play a role in the development and function of synapses. METHODS: Impulsivity was assessed with the Barratt Impulsiveness Scale Version 11 (BIS-11), the Boredom Proneness Scale (BPS) and the TIME paradigm; alcohol problems with the Michigan Alcoholism Screening Test (MAST); drug problems with the Drug Abuse Screening Test (DAST-20); and regular tobacco use with a single question. Participants (n=439 Caucasians, 64.7% female) donated buccal cells for genotyping. Six NRXN3 polymorphisms were genotyped: rs983795, rs11624704, rs917906, rs1004212, rs10146997 and rs8019381. A dual luciferase assay was conducted to determine whether allelic variation at rs917906 regulated gene expression. RESULTS: In general, impulsivity was significantly higher in those who regularly used tobacco and/or had alcohol or drug problems. In men, there were modest associations between rs11624704 and attentional impulsivity (p=0.005) and between rs1004212 and alcohol problems (p=0.009). In women, there were weak associations between rs10146997 and TIME estimation (p=0.03); and between rs1004212 and drug problems (p=0.03). The dual luciferase assay indicated that C and T alleles of rs917906 did not differentially regulate gene expression in vitro. CONCLUSIONS: Associations between impulsivity, substance use problems and polymorphisms in NRXN3 may be gender specific. Impulsivity is associated with substance use problems and may provide a useful intermediate phenotype for addiction.
Authors: Markus Missler; Weiqi Zhang; Astrid Rohlmann; Gunnar Kattenstroth; Robert E Hammer; Kurt Gottmann; Thomas C Südhof Journal: Nature Date: 2003-06-26 Impact factor: 49.962
Authors: Joshua C Gray; James MacKillop; Jessica Weafer; Kyle M Hernandez; Jianjun Gao; Abraham A Palmer; Harriet de Wit Journal: Psychiatry Res Date: 2017-11-08 Impact factor: 3.222
Authors: Joanna I Giza; Yonwoo Jung; Rachel A Jeffrey; Nichole M Neugebauer; Marina R Picciotto; Thomas Biederer Journal: Neuropsychopharmacology Date: 2012-11-21 Impact factor: 7.853
Authors: Rochelle R Smits; Jeffrey S Stein; Patrick S Johnson; Amy L Odum; Gregory J Madden Journal: Exp Clin Psychopharmacol Date: 2013-02-18 Impact factor: 3.157
Authors: Vassilis N Panagopoulos; Timothy J Trull; Anne L Glowinski; Michael T Lynskey; Andrew C Heath; Arpana Agrawal; Anjali K Henders; Leanne Wallace; Alexandre A Todorov; Pamela A F Madden; Elizabeth Moore; Louisa Degenhardt; Nicholas G Martin; Grant W Montgomery; Elliot C Nelson Journal: Drug Alcohol Depend Date: 2012-12-12 Impact factor: 4.492
Authors: David A Hillis; Liran Yadgary; George M Weinstock; Fernando Pardo-Manuel de Villena; Daniel Pomp; Alexandra S Fowler; Shizhong Xu; Frank Chan; Theodore Garland Journal: Genetics Date: 2020-09-25 Impact factor: 4.562